SMTL ID : 9h7d.1

Human Transthyretin in Complex with 2-(phenylamino)benzoic acid

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.23 Å

Oligo State

homo-tetramer

Ligands

4 x CA: CALCIUM ION(Non-covalent)

CA.1: 2 residues within 4Å: Chain A: E.66, D.99 5 PLIP interactions: 3 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:E.66, A:D.99, A:D.99, H2O.2, H2O.2 CA.3: 1 residues within 4Å: Chain B: E.66 1 PLIP interactions: 1 interactions with chain B Metal complexes: B:E.66 CA.5: 2 residues within 4Å: Chain C: E.66, D.99 5 PLIP interactions: 3 interactions with chain C, 2 Ligand-Water interactions Metal complexes: C:E.66, C:D.99, C:D.99, H2O.4, H2O.5 CA.7: 1 residues within 4Å: Chain D: E.66 1 PLIP interactions: 1 interactions with chain D Metal complexes: D:E.66

4 x EHO: 2-phenylazanylbenzoic acid(Non-covalent)

EHO.2: 10 residues within 4Å: Chain A: K.15, L.17, A.108, L.110 Chain C: K.15, L.17, A.108, L.110, T.119 Ligands: EHO.6 9 PLIP interactions: 4 interactions with chain C, 5 interactions with chain A Hydrophobic interactions: C:A.108, C:L.110, C:T.119, A:L.17, A:A.108, A:L.110, A:L.110 Salt bridges: C:K.15, A:K.15 EHO.4: 15 residues within 4Å: Chain B: K.15, L.17, T.106, A.108, L.110, S.117, T.119, V.121 Chain D: K.15, L.17, A.108, L.110, S.117, T.119 Ligands: EHO.8 8 PLIP interactions: 4 interactions with chain D, 4 interactions with chain B Hydrophobic interactions: D:L.17, D:A.108, D:L.110, B:T.106, B:A.108, B:V.121 Salt bridges: D:K.15, B:K.15 EHO.6: 10 residues within 4Å: Chain A: K.15, L.17, A.108, L.110, T.119 Chain C: K.15, L.17, A.108, L.110 Ligands: EHO.2 9 PLIP interactions: 5 interactions with chain C, 4 interactions with chain A Hydrophobic interactions: C:L.17, C:A.108, C:L.110, C:L.110, A:A.108, A:L.110, A:T.119 Salt bridges: C:K.15, A:K.15 EHO.8: 15 residues within 4Å: Chain B: K.15, L.17, A.108, L.110, S.117, T.119 Chain D: K.15, L.17, T.106, A.108, L.110, S.117, T.119, V.121 Ligands: EHO.4 8 PLIP interactions: 4 interactions with chain D, 4 interactions with chain B Hydrophobic interactions: D:T.106, D:A.108, D:V.121, B:L.17, B:A.108, B:L.110 Salt bridges: D:K.15, B:K.15

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chen, W., Fragment-Based Drug Discovery for Transthyretin Kinetic Stabilisers Using a Novel Capillary Zone Electrophoresis Method. Biorxiv (2025)

Release Date

2025-03-12

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin

Related Entries With Identical Sequence